RENEW PHARMACEUTICALS LIMITED

Renew Pharmaceuticals Limited is a science‑driven healthcare company dedicated to delivering trusted solutions that improve clinical outcomes for clinicians and patients worldwide. Building on a strong foundation of research, innovation and a commitment to better health, the firm develops and commercialises pioneering technologies across the EMEA region and the Americas.

The company’s flagship portfolio centres on the Diagnostic Green brand, which combines indocyanine‑green (ICG) imaging agents with the handheld IC Flow™ Imaging System to enhance fluorescence‑guided procedures. In parallel, Renew is advancing PerfusionWorks, an AI‑powered software platform that quantifies surgical fluorescence in real‑time, providing surgeons with objective data for tissue‑perfusion assessment. These products exemplify Renew’s focus on high‑quality pharmaceuticals, medical devices and data‑driven decision support tools.

Led by Managing Director Declan Cassells, whose two decades of experience span senior roles at Medtronic, Conor Medsystems and other multinational firms, the team brings deep expertise across clinical, regulatory, commercial and operational domains. Guided by values of respect, excellence, customer commitment, enthusiasm and bravery, Renew Pharma works closely with clinicians, surgeons and healthcare partners to translate cutting‑edge science into tangible, life‑changing solutions.